SURVIVAL OF PATIENTS WITH MELANOMA METASTATIC BRAIN METASTASES IN THE ERA OF NOVEL SYSTEMIC THERAPIES IN CARDIFF, WALES

被引：0
|
作者：
Pasquale, Joseph [2 ]
Ocen, Joanita [1 ]
Powell, James [1 ]
Kumar, Satish [1 ]
机构：
[1] Velindre Canc Ctr, Cardiff, S Glam, Wales
[2] Univ Wales Hosp, Cardiff, S Glam, Wales
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz167.055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Survival in melanoma brain metastases in the era of novel systemic therapies
    Merola, Joseph P.
    Ocen, Joanita
    Kumar, Satish
    Powell, James
    Hayhurst, Caroline
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [2] Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy
    Tio, Martin
    Wang, Xuan
    Carlino, Matteo S.
    Shivalingam, Brindha
    Fogarty, Gerald B.
    Guminski, Alexander D.
    Lo, Serigne
    Hong, Angela M.
    Menzies, Alexander M.
    Long, Georgina V.
    PIGMENT CELL & MELANOMA RESEARCH, 2018, 31 (04) : 509 - 515
  • [3] Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies
    Song, Yun
    Tieniber, Andrew D.
    Gimotty, Phyllis A.
    Mitchell, Tara C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Fraker, Douglas L.
    Karakousis, Giorgos C.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4621 - 4630
  • [4] Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies
    Yun Song
    Andrew D. Tieniber
    Phyllis A. Gimotty
    Tara C. Mitchell
    Ravi K. Amaravadi
    Lynn M. Schuchter
    Douglas L. Fraker
    Giorgos C. Karakousis
    Annals of Surgical Oncology, 2019, 26 : 4621 - 4630
  • [5] Improved Survival of Patients With Melanoma Brain Metastases in the Era of Targeted BRAF and Immune Checkpoint Therapies
    Sloot, Sarah
    Chen, Yian A.
    Zhao, Xiuhua
    Weber, Jamie L.
    Benedict, Jacob J.
    Mule, James J.
    Smalley, Keiran S.
    Weber, Jeffrey S.
    Zager, Jonathan S.
    Forsyth, Peter A.
    Sondak, Vernon K.
    Gibney, Geoffrey T.
    CANCER, 2018, 124 (02) : 297 - 305
  • [6] Metastatic melanoma: prognostic factors and survival in patients with brain metastases
    Frinton, E.
    Tong, D.
    Tan, J.
    Read, G.
    Kumar, V.
    Kennedy, S.
    Lim, C.
    Board, R. E.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 507 - 512
  • [7] METASTATIC MELANOMA: PROGNOSTIC FACTORS AND SURVIVAL IN PATIENTS WITH BRAIN METASTASES
    Frinton, Emily
    Board, Ruth
    ANTICANCER RESEARCH, 2016, 36 (12) : 6717 - 6717
  • [8] Metastatic melanoma: prognostic factors and survival in patients with brain metastases
    Frinton, E.
    Tong, D.
    Tan, J.
    Read, G.
    Kumar, V.
    Kennedy, S.
    Lim, C. C.
    Board, R.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S124 - S124
  • [9] Metastatic melanoma: prognostic factors and survival in patients with brain metastases
    E. Frinton
    D. Tong
    J. Tan
    G. Read
    V. Kumar
    S. Kennedy
    C. Lim
    R. E. Board
    Journal of Neuro-Oncology, 2017, 135 : 507 - 512
  • [10] The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: Opportunities and unanswered questions
    Murrell, Jack
    Board, Ruth
    CANCER TREATMENT REVIEWS, 2013, 39 (08) : 833 - 838
12345